BRNS: Barinthus Biotherapeutics Company Short-Term Debt
Barinthus Biotherapeutics ensures vaccine integrity through an optimized cold chain, maintaining high margins. The brand's scientific authority in combating viruses strengthens its market position. The organization's short-term debt reflects liability dynamics, where the parameter value equals 0.00. The asset's stability is further bolstered by British jurisdiction, which protects the company's developments from global political conflicts.
Metric breakdowns and analytics for Barinthus Biotherapeutics Corp (BRNS)
- current quotes and average value forecast:
- market capitalization information:
- shareholders' equity book value data:
- debt and liquidity data:
Total Debt to Capital Barinthus Biotherapeutics|BRNS - Ratio of Long-Term Indebtedness to Capital|Short-Term Debt to Equity Barinthus Biotherapeutics|BRNS - Company Total Debt|Debt to Book Capitalization Ratio Barinthus Biotherapeutics plc|BRNS - Company Long-Term Liabilities|Company Current Liabilities Barinthus Biotherapeutics|Quick Liquidity barinthusbio.com
- net income and valuation multiples indicators:
Initial company analysis:BRNS - Barinthus Biotherapeutics plc
Short-term debt measures the aggregate of obligations with a maturity of up to one year, determining the current liquidity and financial resilience of a business against sudden shocks. An analysis of short-term accounts payable and loans on GURU.Markets allows for an assessment of the risks facing Barinthus Biotherapeutics (BRNS), whose development costs for T-cell vaccines against hepatitis B require strict control of borrowed capital to maintain high capitalization potential.
Competitor analysis
ARGX - Company Short-Term Debt|Company Short-Term Loans and Borrowings BNTX (BioNTech Inc.)|Abivax (ABVX) - Company Short-Term Debt|Company Current Liabilities ADMA Corp|PTGX (Protagonist Therapeutics) - Company Short-Term Debts|Company Short-Term Debts immunovant.com|Company Current Liabilities KNSA (Kiniksa)|GRFS (Grifols SA) - Company Short-Term Loans and Borrowings|Company Short-Term Debts ADPT (Adaptive Biotechnologies Corp)|Short-Term Debt Volume Celldex Corp (CLDX)|AUPH - Company Short-Term Debt|biocryst.com (BCRX) - Company Current Liabilities|Vera Therapeutics (VERA) - Company Short-Term Debt|Company Current Liabilities Dianthus Therapeutics Inc|Company Current Liabilities PHVS|Company Short-Term Debts abcellera.com|Company Short-Term Debt Tourmaline Bio, Inc. (TRML)|precigen.com - Company Short-Term Indebtedness|Company Short-Term Debts PHAR (Pharming Group)|Nektar Therapeutics Inc (NKTR) - Short-Term Debt|Upstream Bio Corp - Company Short-Term Debts|ZBIO: Company Short-Term Debt|IMNM: Company Short-Term Debts|gossamerbio.com (GOSS) - Company Short-Term Debts|Company Short-Term Debt KalVista Pharmaceuticals, Inc.|SEPN: Company Short-Term Loans and Borrowings|Company Short-Term Debts PVLA|Short-Term Debt Volume Savara Pharma|Company Short-Term Debt Rigel Pharmaceuticals RIGL|ANAB: Company Short-Term Indebtedness|ATXS: Company Current Liabilities|enGene Holdings Inc - Amount of Current Liabilities|RAPT: Company Short-Term Debts|Aerovate Therapeutics - Company Short-Term Loans and Borrowings|Company Current Liabilities ACRS|Company Short-Term Debts kyvernatx.com|Company Short-Term Debt Tiziana Life Sciences Ltd (TLSA)|Short-Term Debt Volume Cabaletta Bio Inc.|Ventyx Bio - Company Current Liabilities|Company Short-Term Loans and Borrowings THTX|Avalo Therapeutics, Inc - Company Short-Term Debts|ELDN: Company Short-Term Debt|AGEN: Company Short-Term Debts|CLYM - Short-Term Debt Volume|Company Short-Term Debt Zura Bio|Short-Term Debt aTyr Pharmaceuticals ATYR|Company Current Liabilities ADAG (Adagene)|Amount of Current Liabilities IMA|Company Short-Term Debts STTK (Shattuck Labs)|Company Short-Term Loans and Borrowings EQ|Connect Pharma - Company Short-Term Debts|Short-Term Debt Immunic, Inc.|atarabio.com (ATRA) - Company Short-Term Debt|InflaRx - Company Short-Term Loans and Borrowings|XFOR (X4 Pharmaceuticals, Inc.) - Company Short-Term Debts|Company Short-Term Debts Adicet|Company Short-Term Debt Celularity Inc. (CELU)|INMB: Current Liabilities|Company Short-Term Debts KZR (Kezar Life Sciences)|sabbiotherapeutics.com (SABS) - Short-Term Debt|AKTX: Company Current Liabilities|ENLV - Company Short-Term Debts|QTTB (q32bio.com) - Company Current Liabilities|GOVX: Amount of Current Liabilities|EDSA (Edesa Biotech, Inc.) - Company Short-Term Debts|ibioinc.com (IBIO) - Short-Term Debt Volume|Company Short-Term Debts CARM|Company Current Liabilities XTL Biopharmaceuticals Ltd XTLB|Company Short-Term Debt Bolt Biotherapeutics, Inc. BOLT|Short-Term Debt Volume HCW Biologics, Inc. (HCWB)|Aptevo - Company Short-Term Debts|AIM: Company Short-Term Debt|aditxt.com (ADTX) - Company Short-Term Debt|GRI Bio Inc - Company Short-Term Loans and Borrowings|Company Short-Term Debt XORTX|Company Short-Term Indebtedness HIND (Vyome Therapeutics)|Company Short-Term Debt Revelation Biosciences (REVB)|Short-Term Debt Volume indaptusrx.com|Company Short-Term Debt Scinai Immunotherapeutics Ltd. SCNI|CALI (CalciMedica Inc) - Current Liabilities|Affimed Therapeutics - Company Short-Term Debts|Company Short-Term Loans and Borrowings ALLK (Allakos Inc.)|HOOK: Company Short-Term Debts|IGM Biosciences (IGMS) - Company Short-Term Debts|Company Short-Term Debt iTeos Therapeutics, Inc.|OCEA: Company Short-Term Loans and Borrowings|Company Short-Term Debt TC BioPharm (Holdings) PLC (TCBP)|Company Current Liabilities Third Harmonic Bio Inc THRD